11/20
01:19 pm
cvac
Is the Options Market Predicting a Spike in CureVac (CVAC) Stock? [Yahoo! Finance]
Medium
Report
Is the Options Market Predicting a Spike in CureVac (CVAC) Stock? [Yahoo! Finance]
11/19
06:41 pm
cvac
Is CureVac N.V. (CVAC) the Best German Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is CureVac N.V. (CVAC) the Best German Stock to Buy Now? [Yahoo! Finance]
11/13
02:26 am
cvac
CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ... [Yahoo! Finance]
Low
Report
CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ... [Yahoo! Finance]
11/12
07:49 am
cvac
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update [Yahoo! Finance]
Low
Report
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update [Yahoo! Finance]
11/12
07:20 am
cvac
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
Neutral
Report
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
11/7
07:30 am
cvac
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
Low
Report
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
11/4
07:35 am
cvac
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer [Yahoo! Finance]
Medium
Report
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer [Yahoo! Finance]
11/4
07:20 am
cvac
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
Medium
Report
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
11/4
07:15 am
cvac
CureVac to Present at the 12th International mRNA Health Conference
Medium
Report
CureVac to Present at the 12th International mRNA Health Conference
10/28
08:40 am
cvac
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yahoo! Finance]
Low
Report
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yahoo! Finance]
10/28
08:10 am
cvac
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
Low
Report
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
10/8
06:32 pm
cvac
CureVac: Back To Square One [Seeking Alpha]
Low
Report
CureVac: Back To Square One [Seeking Alpha]
10/1
07:04 am
cvac
CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms [Yahoo! Finance]
Medium
Report
CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms [Yahoo! Finance]
9/16
10:09 am
cvac
CureVac (NASDAQ: CVAC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock.
Low
Report
CureVac (NASDAQ: CVAC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock.
9/13
08:15 am
cvac
CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
Medium
Report
CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
9/12
07:24 am
cvac
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program [Yahoo! Finance]
Low
Report
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program [Yahoo! Finance]
9/12
07:15 am
cvac
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program
Low
Report
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program
9/9
07:15 am
cvac
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
Medium
Report
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress